New Key Statistics Module, Z-Score and F-Score
SHSE:603351 Key Ratios
Market Cap ¥ M | 3,276.27 |
Enterprise Value ¥ M | 3,403.34 |
P/E(ttm) | 22.40 |
PE Ratio without NRI | 23.35 |
Forward PE Ratio | -- |
Price/Book | 1.96 |
Price/Sales | 2.43 |
Price/Free Cash Flow | 20.28 |
Price/Owner Earnings | 12,095.00 |
Payout Ratio % | 0.29 |
Revenue (TTM) ¥ M | 1,327.00 |
EPS (TTM) ¥ | 1.08 |
Beneish M-Score | -2.55 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -1.30 |
y-y EBITDA Growth Rate % | 46.30 |
EV-to-EBIT | 18.77 |
EV-to-EBITDA | 18.77 |
PEG | -- |
Shares Outstanding M | 135.44 |
Net Margin (%) | 11.06 |
Operating Margin % | 13.03 |
Pre-tax Margin (%) | 12.53 |
Quick Ratio | 0.87 |
Current Ratio | 1.16 |
ROA % (ttm) | 6.39 |
ROE % (ttm) | 9.12 |
ROIC % (ttm) | 7.17 |
Dividend Yield % | 1.24 |
Altman Z-Score | 4.35 |
SHSE:603351 Number of Guru Trades
SHSE:603351 Volume of Guru Trades
Gurus Latest Trades with SHSE:603351
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603351 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Well Pharmaceutical Group Co Ltd Insider Transactions
No Available Data